The Board granted a 30 percent disability rating for sarcoidosis from February 28, 2023, and denied higher ratings for lumbar spine degenerative arthritis, left lower extremity radiculopathy, and major depressive disorder with generalized anxiety disorder.
The deciding factor: The evidence supports a finding that the appellant's service-connected sarcoidosis manifested with symptoms more nearly approximating pulmonary involvement with persistent symptoms requiring chronic low dose (maintenance) or intermittent corticosteroids from February 28, 2023, but not earlier. The other claims were denied due to insufficient evidence of increased severity.
- Claimed conditions
- lumbar spine degenerative arthritis, left lower extremity radiculopathy, sarcoidosis, major depressive disorder with generalized anxiety disorder
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- November 19, 2025
- Citation
- A25100602
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.